Portfolio company
VIVEbiotech
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
VIVEbiotech manufactures lentiviral vectors for pharmaceutical and biotechnology companies developing gene and cell therapies.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Genezen
This company manufactures viral vectors for biotechnology and pharmaceutical firms developing cell and gene therapies.
ViroCell
The company designs and manufactures viral vectors for academic and corporate innovators developing cell and gene therapies for clinical trials.
SIRION Biotech
The company develops and manufactures viral vector technologies for researchers and pharmaceutical firms in the cell and gene therapy sectors.
Lentitek
This company develops manufacturing technologies for lentiviral vectors to help cell and gene therapy developers improve the production of advanced cancer treatments.
Fuse Vectors
This company develops a cell-free enzymatic platform to manufacture viral vectors for pharmaceutical and biotechnology clients to produce gene therapies.
Brammer Bio
This contract development and manufacturing organisation produces viral vectors for pharmaceutical and biotechnology companies developing gene and cell therapies.
Gene Therapy Delivery Methods
This company develops viral and non-viral vector platforms to provide genetic material delivery solutions for biotechnology firms and healthcare providers.
Theravectys
Theravectys develops lentiviral vector-based vaccines and immunotherapies to treat cancer and infectious diseases for the pharmaceutical and biotechnology sectors.
